FDA, COVID and Novavax
Digest more
The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the coronavirus.
WHO members on Tuesday adopted a treaty that outlines how to prepare for and respond to pandemics. One country missing: the U.S.
Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or eligibility changes this fall.
ABS-CBN on MSN15m
WHO adopts landmark pandemic agreementGENEVA: The UN health agency on Tuesday (May 20) adopted a landmark Pandemic Agreement on tackling future health crises, struck after more than three years of negotiations sparked by the COVID-19 crisis.
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Robert F. Kennedy Jr. secures a prominent health role, pledging reform in vaccine approval. The FDA plans significant changes under Dr. Vinay Prasad's leadership, sparking debates on the future of vaccinations.
News-Medical.Net on MSN8d
New AI tool predicts viral mutations to help future-proof COVID vaccinesA novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that anticipate future SARS-CoV-2 escape mutations, offering a powerful tool to test and strengthen next-generation vaccines.
The success of mRNA-based COVID-19 vaccines (Pfizer-BioNTech, Moderna) has opened new possibilities for treating other diseases, including HIV, Zika, and cancer. This technology allows faster development and scalability compared to traditional methods.
"We show that if you can see where a virus is evolving ahead of time, you can begin to make future-proof vaccines," said first author Noor Youssef, a scientific lead for the Predictive Modeling for Vaccine Design group in the Marks lab at HMS.
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust make it challenging to craft effective public health responses.
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.
Scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for viruses and enhanced cancer therapies.
Feedback